Back
Corvus Pharmaceuticals Vs. Ingevity Industry Stock Comparison
Sell
48
CRVS
Corvus Pharmaceuticals
Last Price:
5.63
Seasonality Move:
-5.47%
Sell
1
NGVT
Ingevity
Last Price:
37.03
Seasonality Move:
10.62%
Sell
48
Corvus Pharmaceuticals (CRVS)
is a Sell
Is Corvus Pharmaceuticals a Buy, Sell or Hold?
- The current Corvus Pharmaceuticals [CRVS] share price is $5.25. The Score for CRVS is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
- CRVS is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
1
Ingevity (NGVT)
is a Sell
Is Ingevity a Buy, Sell or Hold?
- The current Ingevity [NGVT] share price is $33.06. The Score for NGVT is 1, which is 98% below its historic median score of 50, and infers higher risk than normal.
- NGVT is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
CRVS Stock Price Chart
What is Corvus Pharmaceuticals's stock price today?
-
The Corvus Pharmaceuticals share price today is $5.25
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CRVS is experiencing selling pressure, which indicates risk of future bearish movement.
NGVT Stock Price Chart
CRVS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.3 | Buy |
Relative Strength Index (14 RSI): | 58.18 | Buy |
Chaikin Money Flow: | -293962 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (4.35 - 5.53) | Buy |
Bollinger Bands (100): | (1.85 - 4.41) | Buy |
NGVT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.25 | Sell |
Relative Strength Index (14 RSI): | 34.38 | Sell |
Chaikin Money Flow: | -258474 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (35.39 - 40.21) | Sell |
Bollinger Bands (100): | (36.97 - 47.79) | Sell |
CRVS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 5.19 | Buy |
20-day SMA: | 5.14 | Buy |
50-day SMA: | 4.22 | Buy |
200-day SMA: | 2.53 | Buy |
8-day EMA: | 5.23 | Buy |
20-day EMA: | 5.04 | Buy |
50-day EMA: | 4.32 | Buy |
200-day EMA: | 2.86 | Buy |
NGVT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 38.45 | Sell |
20-day SMA: | 37.7 | Sell |
50-day SMA: | 38.26 | Sell |
200-day SMA: | 44.33 | Sell |
8-day EMA: | 37.5 | Sell |
20-day EMA: | 38.02 | Sell |
50-day EMA: | 39.02 | Sell |
200-day EMA: | 43.99 | Sell |
Corvus Pharmaceuticals Earnings Growth & CRVS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.12 per share, and a decrease next year of $0.07 per share.
Ingevity Earnings Growth & NGVT Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.58 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.69 per share, and an increase next year of $1.18 per share.
Corvus Pharmaceuticals Technical Analysis
Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | Sep 30 | Oct 1 | Oct 2 | Oct 3 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | Oct | |||||||||
20 | 23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Ingevity Technical Analysis
Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | Sep 30 | Oct 1 | Oct 2 | Oct 3 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | Oct | |||||||||
20 | 23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |